Liu Leyuan, Vo Amy, Liu Guoqin, McKeehan Wallace L
Center for Cancer Biology and Nutrition, Institute of Biosciences and Technology, Texas A&M University System Health Science Center, Houston, TX 77030-3303, USA.
Biochem Biophys Res Commun. 2005 Jul 8;332(3):670-6. doi: 10.1016/j.bbrc.2005.05.006.
C19ORF5 is a homologue of microtubule-associated protein MAP1B that interacts with natural paclitaxel-like microtubule stabilizer and candidate tumor suppressor RASSF1A. Although normally distributed throughout the cytosol, C19ORF5 specifically associates with microtubules stabilized by paclitaxel or RASSF1A. At sufficiently high concentrations, C19ORF5 causes mitochondrial aggregation and genome destruction (MAGD). The accumulation on hyperstabilized microtubules coupled to MAGD has been proposed to mediate tumor suppression by the taxoid drug family and RASSF1A. Here, we show that the C-terminus of C19ORF5 (C19ORF5C) interacts with mitochondria-associated DNA binding protein, LRPPRC, in liver cells. Like LRPPRC, C19ORF5 also binds DNA with an affinity and specificity sufficient to be of utility in DNA affinity chromatography to purify homogeneous recombinant C19ORF5C from bacterial extracts. Homogeneous C19ORF5 exhibited no intrinsic DNase activity. Deletion mutagenesis indicated that C19ORF5 selectively binds double stranded DNA through its microtubule binding domain. These results suggest C19ORF5 as a DNA binding protein similar to microtubule-associated proteins tau and MAP2.
C19ORF5是微管相关蛋白MAP1B的同源物,它与天然紫杉醇样微管稳定剂及候选肿瘤抑制因子RASSF1A相互作用。尽管C19ORF5通常分布于整个细胞质中,但它会特异性地与由紫杉醇或RASSF1A稳定的微管结合。在足够高的浓度下,C19ORF5会导致线粒体聚集和基因组破坏(MAGD)。与MAGD相关的超稳定微管上的积累被认为介导了紫杉烷类药物家族和RASSF1A的肿瘤抑制作用。在此,我们表明C19ORF5的C末端(C19ORF5C)在肝细胞中与线粒体相关的DNA结合蛋白LRPPRC相互作用。与LRPPRC一样,C19ORF5也能以足够的亲和力和特异性结合DNA,从而可用于DNA亲和色谱法从细菌提取物中纯化均一的重组C19ORF5C。均一的C19ORF5没有内在的DNA酶活性。缺失诱变表明C19ORF5通过其微管结合结构域选择性地结合双链DNA。这些结果表明C19ORF5是一种类似于微管相关蛋白tau和MAP2的DNA结合蛋白。